Accretive Health, which provides outsourced revenue cycle management services to US hospitals, will see its quiet period end on Monday, June 28th. On May 19th, the company raised $120 million by offering 10 million shares at $12, below the range of $14-$16. Goldman, Sachs & Co., Credit Suisse and J.P. Morgan acted as lead managers on the deal.
